Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & ...

Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been granted accelerated approval by the US Food ...

Medical affairs, situated at the intersection of data and dialogue, is primed to lead this shift. By partnering with ...

The first patient in the UK has been treated by the NHS with CSL Behring’s haemophilia B gene therapy Hemgenix (etranacogene ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise ...

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...